Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
This study is currently recruiting participants.
Study NCT00274170   Information provided by C.R.Darnall Army Medical Center
First Received: January 9, 2006   Last Updated: February 27, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Migraine Headache
Additional conditions recognized in this trial
Emergencies
Headache
Migraine Disorders
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Disease Attributes
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases
Neurologic Manifestations
Pain
Pathologic Processes
Signs and Symptoms
Interventions listed in this trial
Octreotide
Additional drug interventions recognized in this trial
Prochlorperazine
More general drug interventions related to this trial
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antipsychotic Agents
Autonomic Agents
Central Nervous System Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Antagonists
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
C.R.Darnall Army Medical Center


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services